Fat in the liver (NASH)
1 in 4 people in the world have fatty liver
Even with no symptoms, this could be you Fatty liver is a 'silent' disease, which means that most people are completely unaware that they have it. As there are usually no symptoms to alert you to the problem, the fat in the liver
keeps building up, resulting in a condition known as nonalcoholic steatohepatitis (NASH). NASH can lead to cirrhosis (scarring of the liver), liver cancer, the need for liver transplantation, and even death.
Although the cause is unknown, NASH is more likely to be seen in people with type 2 diabetes, high blood pressure, high cholesterol, high triglycerides (a type of fat in the blood) or who are overweight or obese.
Currently, there is no medical treatment available for NASH with fibrosis (initial stage scarring of the liver). The MIRNA clinical research study is investigating a potential treatment for NASH.
I want to apply to this clinical study
The study process in pictures
Step 1 | Before starting the study, we will take time to fully explain the selection process and the conduct of the study by phone.
Step 2 | After the initial phone interview, if you are still interested in taking part in a study, we schedule a preliminary meeting with you during which you may ask all the questions you wish and take the time you require to read over the consent form. This form explains, in detail, the different stages of each study.
Step 3 | You may make a decision at that time to move forward with or terminate the selection process. However, you are under no obligation to make an immediate decision. Based on briefing content, you may take the time necessary to come to a decision and consult with your personal physician or loved ones.
Step 4 | Depending on the nature of the study, some tests or medical examinations may be required. In the majority of cases, these tests or examinations are conducted on Diex Research premises based on your individual availability.
Step 5 | If you are eligible, you may then begin a clinical study with us.